Correlation Between 4D Molecular and Tourmaline Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both 4D Molecular and Tourmaline Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 4D Molecular and Tourmaline Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 4D Molecular Therapeutics and Tourmaline Bio, you can compare the effects of market volatilities on 4D Molecular and Tourmaline Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 4D Molecular with a short position of Tourmaline Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of 4D Molecular and Tourmaline Bio.

Diversification Opportunities for 4D Molecular and Tourmaline Bio

-0.88
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between FDMT and Tourmaline is -0.88. Overlapping area represents the amount of risk that can be diversified away by holding 4D Molecular Therapeutics and Tourmaline Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tourmaline Bio and 4D Molecular is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 4D Molecular Therapeutics are associated (or correlated) with Tourmaline Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tourmaline Bio has no effect on the direction of 4D Molecular i.e., 4D Molecular and Tourmaline Bio go up and down completely randomly.

Pair Corralation between 4D Molecular and Tourmaline Bio

Given the investment horizon of 90 days 4D Molecular Therapeutics is expected to generate 0.98 times more return on investment than Tourmaline Bio. However, 4D Molecular Therapeutics is 1.02 times less risky than Tourmaline Bio. It trades about -0.03 of its potential returns per unit of risk. Tourmaline Bio is currently generating about -0.05 per unit of risk. If you would invest  820.00  in 4D Molecular Therapeutics on August 30, 2024 and sell it today you would lose (33.00) from holding 4D Molecular Therapeutics or give up 4.02% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

4D Molecular Therapeutics  vs.  Tourmaline Bio

 Performance 
       Timeline  
4D Molecular Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days 4D Molecular Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's primary indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Tourmaline Bio 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Tourmaline Bio are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Despite quite fragile primary indicators, Tourmaline Bio disclosed solid returns over the last few months and may actually be approaching a breakup point.

4D Molecular and Tourmaline Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with 4D Molecular and Tourmaline Bio

The main advantage of trading using opposite 4D Molecular and Tourmaline Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 4D Molecular position performs unexpectedly, Tourmaline Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tourmaline Bio will offset losses from the drop in Tourmaline Bio's long position.
The idea behind 4D Molecular Therapeutics and Tourmaline Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Other Complementary Tools

Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets